Ask AI
ProCE Banner Events

Share

Current Advances in Relapsed/Refractory MCL: Expert Guidance for Community Hematology Care Teams

Register now for this interactive, case-based workshop series to hear about recent clinical data on the management of patients with relapsed or refractory MCL and evidence-based integration of new and emerging BTK inhibitors into the treatment algorithm, including data highlighting the disease burden and treatment guideline recommendations. After the meeting, view the on-demand webcast and download the associated slide set for use in your clinic.

Nurse Practitioners/Nurses: 1.00 Nursing contact hour

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Registration not open

Credits Available

1.0

Who Should Attend

This program is intended for community-based medical hematologists/oncologists, pharmacists, advanced practice providers, nurses, and other healthcare professionals involved in the treatment of patients with mantle cell lymphoma.

Time and location

Monday, August 07, 2023

11:30 AM - 12:30 PM Central Time (CT)

Virtual

Private Event | Virtual Group
Dallas, Texas

Agenda

Agenda

  • Welcome and Introduction
  • Overview of Disease Burden in R/R MCL
  • Current and Emerging Roles of BTK Inhibitors in MCL
  • Selecting and Sequencing BTK Inhibitor Therapy in MCL
  • Ongoing Clinical Trials and Future Role of BTK Inhibitor Therapy in MCL
  • Final Thoughts and Audience Question and Answer Session

Location

Venue Name

Private Event | Virtual Group

Address

Private Event | Virtual Group
Dallas, Texas

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge, confidence, competence, and performance of learners in the use of evidence-based and guideline-directed best practices in the care of patients with MCL. 

Target Audience
This program is intended for community-based medical hematologists/oncologists, pharmacists, advanced practice providers, nurses, and other healthcare professionals involved in the treatment of patients with mantle cell lymphoma. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Evaluate available BTK inhibitor data in the treatment of MCL considering the potential impact of safety and efficacy results on clinical practice 
  • Plan BTK inhibitor–based therapeutic strategies for patients with R/R MCL, taking into consideration guideline recommendations and recent practice-changing clinical trial results
  • Manage treatment-related symptom in patients with MCL receiving BTK inhibitor–based therapy to optimize adherence and clinical outcomes
  • Identify patients with MCL who may be eligible for ongoing clinical trials evaluating currently available and emerging BTK inhibitors and BTK inhibitor–based combinations 

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-23-136-L01-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate/Physician Assistant Continuing Medical Education

LogoDescription automatically generated

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by educational grants from Beigene, Ltd. and Lilly.

Contact Information

Contact Clinical Care Options

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.